(Q39404062)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

main subject

chronic myeloid leukemia

0 references

multiple drug resistance

1 reference

1 reference

1 reference

Raquel Ciuvalschi Maia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Paloma Silva de Souza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Flavia da Cunha Vasconcelos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Luis Felipe R Silva

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

31 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

943-956

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Importance of P-glycoprotein at blood-tissue barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

The molecular mysteries underlying P-glycoprotein-mediated multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Introduction to resistance to anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

ABC multidrug transporters: structure, function and role in chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Targeting XIAP for the treatment of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Cancer cells survive with survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Survivin, a cancer target with an emerging role in normal adult tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Cyclosporin A is a broad-spectrum multidrug resistance modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95): a trial of the Eastern Cooperative Oncology Gr

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Cyclosporin A sensitises Bcr-Abl positive cells to imatinib mesylate independently of P-glycoprotein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Pheophorbide a is a specific probe for ABCG2 function and inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Apoptosis, necrosis and cell proliferation-inhibition by cyclosporine A in U937 cells (a human monocytic cell line).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Simultaneous targeting of P-gp and XIAP with siRNAs increases sensitivity of P-gp overexpressing CML cells to imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0323-5

Taxanes, microtubules and chemoresistant breast cancer.

21 January 2018

1 reference

12 December 2020

Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.

1 reference

12 December 2020

Modulators of P-glycoprotein-associated multidrug resistance

1 reference

12 December 2020

Human P-glycoprotein transports cyclosporin A and FK506.

1 reference

12 December 2020

P-glycoprotein and survivin simultaneously regulate vincristine-induced apoptosis in chronic myeloid leukemia cells

1 reference

12 December 2020

Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice

1 reference

12 December 2020

Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemia.

1 reference

12 December 2020

Expression of the IAPs in multidrug resistant tumor cells

1 reference

12 December 2020

siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells

1 reference

12 December 2020

Survivin overexpression correlates with an apoptosis-resistant phenotype in chronic myeloid leukemia cells.

1 reference

12 December 2020

Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma

1 reference

12 December 2020

10.1007/S13277-012-0323-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22290425%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference